{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:49:35Z","timestamp":1776901775807,"version":"3.51.2"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.vaccine.2017.12.062","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T08:10:24Z","timestamp":1515226224000},"page":"833-840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18\u201345"],"prefix":"10.1016","volume":"36","author":[{"given":"James M.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Lock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin M.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub K.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Gurwith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.12.062_b0005","unstructured":"World Health Organization. Cholera fact sheet. WHO; 2017. <http:\/\/www.who.int\/mediacentre\/factsheets\/fs107\/en\/> [accessed June 9, 2017]."},{"key":"10.1016\/j.vaccine.2017.12.062_b0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2471\/BLT.11.093427","article-title":"The global burden of cholera","volume":"90","author":"Ali","year":"2012","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.12.062_b0015","doi-asserted-by":"crossref","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0020","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1017\/S0950268814001186","article-title":"Cholera in the United States, 2001\u20132011: a reflection of patterns of global epidemiology and travel","volume":"143","author":"Loharikar","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.12.062_b0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tmaid.2006.11.003","article-title":"Cholera among Belgian travellers in Turkey in 2005","volume":"5","author":"De Schrijver","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0030","doi-asserted-by":"crossref","first-page":"20572","DOI":"10.2807\/1560-7917.ES2013.18.35.20572","article-title":"Cholera with severe renal failure in an Italian tourist returning from Cuba, July 2013","volume":"18","author":"Mascarello","year":"2013","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2017.12.062_b0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1477-8939(03)00062-0","article-title":"Cholera: assessing the risk to travellers and identifying methods of protection","volume":"1","author":"Steffen","year":"2003","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0040","doi-asserted-by":"crossref","first-page":"30099","DOI":"10.2807\/1560-7917.ES.2016.21.1.30099","article-title":"Imported cholera with acute renal failure after a short business-trip to the Philippines, Germany, October 2015","volume":"21","author":"Slesak","year":"2016","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2017.12.062_b0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tmaid.2012.10.002","article-title":"Cholera gravis associated with acute renal failure in a traveler from Haiti to the United States","volume":"10","author":"Reyes-Corcho","year":"2012","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0050","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.3201\/eid1711.110808","article-title":"Cholera in United States associated with epidemic in hispaniola","volume":"17","author":"Newton","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03014467900003751","article-title":"Genetic susceptibility to cholera","volume":"6","author":"Levine","year":"1979","journal-title":"Ann Hum Biol"},{"key":"10.1016\/j.vaccine.2017.12.062_b0060","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1086\/644779","article-title":"Clinical outcomes in household contacts of patients with cholera in Bangladesh","volume":"49","author":"Weil","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0065","first-page":"777","article-title":"The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients","volume":"38","author":"Mosley","year":"1968","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.12.062_b0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/infdis\/145.4.465","article-title":"Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of vibrio cholerae","volume":"145","author":"Clements","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0075","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/143.6.818","article-title":"Duration of infection-derived immunity to cholera","volume":"143","author":"Levine","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0020-2452(96)85758-7","article-title":"Live oral cholera vaccine: from principle to product","volume":"93","author":"Levine","year":"1995","journal-title":"Bull Inst Pasteur"},{"key":"10.1016\/j.vaccine.2017.12.062_b0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","article-title":"Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR","volume":"332","author":"Levine","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.12.062_b0090","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1128\/iai.60.10.4430-4432.1992","article-title":"Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial","volume":"60","author":"Kotloff","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.12.062_b0095","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","article-title":"Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba three months after vaccination","volume":"67","author":"Tacket","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.12.062_b0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0264-410X(90)90012-B","article-title":"Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults","volume":"8","author":"Cryz","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.062_b0105","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1128\/iai.60.9.3916-3917.1992","article-title":"Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults","volume":"60","author":"Cryz","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.12.062_b0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14760584.2017.1291348","article-title":"PaxVax CVD 103-HgR single-dose live oral cholera vaccine","volume":"16","author":"Levine","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.12.062_b0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/infdis\/166.4.837","article-title":"Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD l03-HgR","volume":"166","author":"Tacket","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0120","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/S0264-410X(00)00101-8","article-title":"Local and systemic immune responses to combined Vibrio cholerae CVD103-HgR and Salmonella typhi Ty21a live oral vaccines after primary immunization and reimmunization","volume":"18","author":"Kollaritsch","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.062_b0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CVI.00601-13","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks","volume":"21","author":"Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.12.062_b0130","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor","volume":"62","author":"Chen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0135","unstructured":"Food and Drug Administration. Biologics license application approval for cholera vaccine, live, oral. Silver Spring, MD; 2016. <https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM506321.pdf>."},{"key":"10.1016\/j.vaccine.2017.12.062_b0140","first-page":"277","article-title":"Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique","volume":"38","author":"Benenson","year":"1968","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.12.062_b0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/jcm.21.2.174-179.1985","article-title":"Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology","volume":"21","author":"Levine","year":"1985","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.12.062_b0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0140-6736(92)92432-F","article-title":"Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk","volume":"340","author":"Swerdlow","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.12.062_b0155","first-page":"1","article-title":"Cholera situation in the Americas: an update","volume":"12","author":"Organization","year":"1991","journal-title":"Epidemiol Bull"},{"key":"10.1016\/j.vaccine.2017.12.062_b0160","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/clinids\/22.6.1108","article-title":"Cholera among Americans living in Peru","volume":"22","author":"Taylor","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0165","doi-asserted-by":"crossref","unstructured":"Eberhart-Phillips J, Bessser RE, Tormey MP, Feikin D, Araneta MR, Wells J, et al. An outbreak of cholera from food served on an international aircraft. Epidemiol Infect 1996;116:9\u201313. doi: 10.1017\/S0022172400023688.","DOI":"10.1017\/S0950268800058891"},{"key":"10.1016\/j.vaccine.2017.12.062_b0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/00365540510026409","article-title":"Mixed diarrhoeal infection caused by Vibrio cholerae and several other enteric pathogens in a 4-year-old child returning to Germany from Pakistan","volume":"37","author":"Enzensberger","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/IPC.0b013e318218334d","article-title":"A case of imported cholera in Romania in 2009","volume":"20","author":"Neghina","year":"2012","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.vaccine.2017.12.062_b0180","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2217\/FMB.15.51","article-title":"Evidence for CVD 103-HgR as an effective single-dose oral cholera vaccine","volume":"10","author":"Jackson","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2017.12.062_b0185","first-page":"335","article-title":"A serological survey for cholera antibodies in rural East Pakistan. 2. A comparison of antibody titres in the immunized and control population of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate","volume":"38","author":"Mosley","year":"1968","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.12.062_b0190","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/infdis\/151.2.236","article-title":"Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection","volume":"151","author":"Glass","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.062_b0195","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.062_b0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.12.062_b0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/iai.56.1.161-167.1988","article-title":"Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques","volume":"56","author":"Levine","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.12.062_b0210","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/mr.47.4.510-550.1983","article-title":"New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development","volume":"47","author":"Levine","year":"1983","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2017.12.062_b0215","unstructured":"Swiss Serum and Vaccine Institute Berne. Orochol [package insert]; 2000."},{"key":"10.1016\/j.vaccine.2017.12.062_b0220","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/iai.62.4.1480-1483.1994","article-title":"Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR","volume":"62","author":"Kaper","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.12.062_b0225","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2003.12.033","article-title":"Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR","volume":"22","author":"Viret","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17318236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17318236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:23:25Z","timestamp":1759400605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17318236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0264410X17318236"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18\u201345","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}